These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32969135)

  • 1. Does glycemic control affect outcome of COVID-19?
    Bloomgarden Z
    J Diabetes; 2020 Dec; 12(12):868-869. PubMed ID: 32969135
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical characteristics and outcomes of COVID-19 in patients with type 2 diabetes in Turkey: A nationwide study (TurCoviDia).
    Sonmez A; Demirci I; Haymana C; Tasci I; Dagdelen S; Salman S; Ata N; Sahin I; Emral R; Cakal E; Atmaca A; Sahin M; Celik O; Demir T; Ertugrul D; Unluturk U; Caglayan M; Satman I
    J Diabetes; 2021 Jul; 13(7):585-595. PubMed ID: 33655669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycemic control in type 1 diabetes mellitus and COVID-19 lockdown: What comes after a "quarantine"?
    Ceconi V; Barbi E; Tornese G
    J Diabetes; 2020 Dec; 12(12):946-948. PubMed ID: 32909344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycemic Control of Patients with Type 1 Diabetes Using an Insulin Pump Before and During the COVID-19-Associated Quarantine.
    Barmpagianni A; Lambadiari V; Papazafiropoulou A; Kountouri A; Stergiou A; Melidonis A; Liatis S
    Diabetes Technol Ther; 2021 Apr; 23(4):320-321. PubMed ID: 33232615
    [No Abstract]   [Full Text] [Related]  

  • 5. Seasonal flu and COVID-19 recommendations for children, adolescents and young adults with diabetes.
    Scaramuzza AE; Rabbone I; Maffeis C; Schiaffini R;
    Diabet Med; 2021 Jan; 38(1):e14427. PubMed ID: 33067861
    [No Abstract]   [Full Text] [Related]  

  • 6. COVID-19 and diabetes mellitus. Importance of glycemic control.
    Alonso N; Batule S
    Clin Investig Arterioscler; 2021; 33(3):148-150. PubMed ID: 34074468
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of COVID-19 pandemic on glycemic control among outpatients with type 2 diabetes in Japan: A hospital-based survey from a country without lockdown.
    Tanji Y; Sawada S; Watanabe T; Mita T; Kobayashi Y; Murakami T; Metoki H; Akai H
    Diabetes Res Clin Pract; 2021 Jun; 176():108840. PubMed ID: 33933499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managing type 2 diabetes mellitus during COVID-19 pandemic: The bittersweet.
    Yehya A; Carbone S
    Diabetes Metab Res Rev; 2021 Jan; 37(1):e3360. PubMed ID: 32488991
    [No Abstract]   [Full Text] [Related]  

  • 9. Factors Related to Improvement of Glycemic Control Among Adults with Type 1 Diabetes During Lockdown Due to COVID-19.
    Moreno-Domínguez Ó; González-Pérez de Villar N; Barquiel B; Hillman-Gadea N; Gaspar-Lafuente R; Arévalo-Gómez M; Herranz L
    Diabetes Technol Ther; 2021 May; 23(5):399-400. PubMed ID: 33237817
    [No Abstract]   [Full Text] [Related]  

  • 10. Glycemic Control Improvement in Italian Children and Adolescents With Type 1 Diabetes Followed Through Telemedicine During Lockdown Due to the COVID-19 Pandemic.
    Predieri B; Leo F; Candia F; Lucaccioni L; Madeo SF; Pugliese M; Vivaccia V; Bruzzi P; Iughetti L
    Front Endocrinol (Lausanne); 2020; 11():595735. PubMed ID: 33424771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors contributing to glycemic control in diabetes mellitus patients complying with home quarantine during the coronavirus disease 2019 (COVID-19) epidemic.
    Tao J; Gao L; Liu Q; Dong K; Huang J; Peng X; Yang Y; Wang H; Yu X
    Diabetes Res Clin Pract; 2020 Dec; 170():108514. PubMed ID: 33068663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sedentariness and physical activity in type 2 diabetes during the COVID-19 pandemic.
    Balducci S; Coccia EM
    Diabetes Metab Res Rev; 2021 Feb; 37(2):e3378. PubMed ID: 32592519
    [No Abstract]   [Full Text] [Related]  

  • 13. Potential late effects of SARS-CoV-2 (COVID-19) infection: parallels to cancer late effects.
    Phipps RP; Sime PJ; Phipps CR
    Cancer Metastasis Rev; 2021 Mar; 40(1):1-2. PubMed ID: 33537895
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute myocardial infarction in the Covid-19 era: Incidence, clinical characteristics and in-hospital outcomes-A multicenter registry.
    Fardman A; Zahger D; Orvin K; Oren D; Kofman N; Mohsen J; Tsafrir O; Asher E; Rubinshtein R; Jamal J; Efraim R; Halabi M; Shacham Y; Fortis LH; Cohen T; Klempfner R; Segev A; Beigel R; Matetzky S
    PLoS One; 2021; 16(6):e0253524. PubMed ID: 34143840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased stress, weight gain and less exercise in relation to glycemic control in people with type 1 and type 2 diabetes during the COVID-19 pandemic.
    Ruissen MM; Regeer H; Landstra CP; Schroijen M; Jazet I; Nijhoff MF; Pijl H; Ballieux BEPB; Dekkers O; Huisman SD; de Koning EJP
    BMJ Open Diabetes Res Care; 2021 Jan; 9(1):. PubMed ID: 33431602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronobiology in response to COVID-19.
    Cermakian N; Harrington ME
    J Biol Rhythms; 2021 Feb; 36(1):3. PubMed ID: 33543668
    [No Abstract]   [Full Text] [Related]  

  • 17. Glycemic control in people with type 1 diabetes using a hybrid closed loop system and followed by telemedicine during the COVID-19 pandemic in Italy.
    Longo M; Caruso P; Petrizzo M; Castaldo F; Sarnataro A; Gicchino M; Bellastella G; Esposito K; Maiorino MI
    Diabetes Res Clin Pract; 2020 Nov; 169():108440. PubMed ID: 32926958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycaemic control in the paediatric and young adult population with type 1 diabetes following a single telehealth visit - what have we learned from the COVID-19 lockdown?
    Rachmiel M; Lebenthal Y; Mazor-Aronovitch K; Brener A; Levek N; Levran N; Chorna E; Dekel M; Barash G; Landau Z; Pinhas-Hamiel O
    Acta Diabetol; 2021 Jun; 58(6):697-705. PubMed ID: 33511493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emotional Burden Associated with COVID-19: Trust and Communication in Cancer Care.
    Bergerot CD; Philip EJ
    Cancer Invest; 2021 Jan; 39(1):1-2. PubMed ID: 33148064
    [No Abstract]   [Full Text] [Related]  

  • 20. COVID-19 in cancer patients: clinical characteristics and outcome-an analysis of the LEOSS registry.
    Rüthrich MM; Giessen-Jung C; Borgmann S; Classen AY; Dolff S; Grüner B; Hanses F; Isberner N; Köhler P; Lanznaster J; Merle U; Nadalin S; Piepel C; Schneider J; Schons M; Strauss R; Tometten L; Vehreschild JJ; von Lilienfeld-Toal M; Beutel G; Wille K;
    Ann Hematol; 2021 Feb; 100(2):383-393. PubMed ID: 33159569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.